Skip to main content
. 2019 Mar 7;35(9):1547–1553. doi: 10.1093/ndt/gfz037

Table 1.

Baseline characteristics of the study sample

Clinical characteristic Controls CKD Total P-value
Number (%) 45 (8) 516 (92) 561 (100)
Age (years) 62.3 ± 9 69 ± 10.1 68.4 ± 10.2 <0.0001
Men, n (%) 42 (93.3) 485 (94) 527 (93.9) 0.86
Blacks, n (%) 6 (13.3) 113 (21.9) 119 (21.2) 0.18
Age >60 years, n (%) 29 (64.4) 434 (84.1) 463 (82.5) <0.001
Age categories (years) <0.001
 <40 0 (0) 4 (0.8) 4 (0.7)
 40–50 5 (11.1) 18 (3.5) 23 (4.1)
 50–60 11 (24.4) 60 (11.6) 71 (12.7)
 60–70 23 (51.1) 204 (39.5) 227 (40.5)
 80–90 4 (8.9) 153 (29.7) 157 (28)
 >90 2 (4.4) 77 (14.9) 79 (14.1)
Weight (kg) 86.5 ± 15.2 93.2 ± 18.4 92.7 ± 18.2 0.02
Height (cm) 176.6 ± 7.6 173.1 ± 8 173.4 ± 8 <0.01
BMI (kg/m2) 27.6 ± 3.9 31.1 ± 5.4 30.8 ± 5.4 <0.0001
FFM (kg) 61.2 ± 8.6 59.5 ± 10.3 59.6 ± 10.2 0.29
FM (kg) 25.4 ± 9.6 33.8 ± 12.1 33.1 ± 12.2 <0.0001
BF% 28.6 ± 6.9 35.4 ± 8 34.9 ± 8.2 <0.0001
Diabetes mellitus, n (%) 0 (0) 338 (65.5) 338 (60.2) <0.0001
Tobacco use, n (%) <0.01
 Never used 13 (28.9) 100 (19.4) 113 (20.1)
 Past use 32 (71.1) 320 (62) 352 (62.7)
 Current use 0 (0) 96 (18.6) 96 (17.1)
Myocardial infarction, n (%) 0 (0) 142 (27.5) 142 (25.3) <0.0001
Congestive heart failure, n (%) 0 (0) 102 (19.8) 102 (18.2) <0.001
Stroke, n (%) 0 (0) 57 (11) 57 (10.2) 0.02
CKD stage <0.0001
 1 or 2 45 (100) 55 (10.7) 100 (17.8)
 3 0 (0) 350 (67.8) 350 (62.4)
 4 0 (0) 111 (21.5) 111 (19.8)
eGFR (mL/min/1.73 m2) 88.6 ± 11.6 41.5 ± 15.1 45.3 ± 19.6 <0.0001
Albuminuria stage <0.0001
 No albuminuria 44 (97.8) 199 (38.6) 243 (43.3)
 High albuminuria 1 (2.2) 153 (29.7) 154 (27.5)
 Very high albuminuria 0 (0) 164 (31.8) 164 (29.2)
Albumin/creatinine ratio (mg/g) 5.3 ± 11.8 602.2 ± 1316.2 554.3 ± 1272.6 <0.01